文献速递心脏核医学

瑞加诺生心率反应与死亡及心衰住院的关联因射血分数而异:PET心肌灌注显像研究

Differential association of heart rate response to regadenoson with death and heart failure hospitalizations according to ejection fraction in patients undergoing positron emission tomography myocardial perfusion imaging.
PubMed 文献 · J Nucl Cardiol · 2025-10-08

本研究纳入2019至2024年接受铷-82 PET心肌灌注显像及瑞加诺生负荷试验的连续患者,评估心率反应比(HRR)与死亡或心衰住院复合终点的关联。中位随访553天期间,7808例患者中发生1288例主要终点事件。

要点

  • HRR增高与死亡或心衰住院复合终点发生率降低独立相关(多变量HR 0.60)。
  • 该关联独立于传统危险因素及PET参数包括心肌血流储备。

核心结论

  • 瑞加诺生负荷试验后HRR对死亡和心衰住院的预后价值在射血分数保留的患者中最为显著,且独立于传统危险因素和PET参数包括心肌血流储备。

研究设计与样本

  • 连续纳入2019至2024年接受铷-82 PET及瑞加诺生负荷试验的患者,共7808例。
  • 采用Andersen-Gill扩展Cox模型评估HRR与主要终点(死亡或心衰住院复合终点)的关联,并使用限制性立方样条处理非线性。
  • 报告比较HRR第75百分位(参照)与第25百分位的四分位间风险比(HR)。

主要发现

  • 中位随访553天(IQR 232至941天)期间,7808例患者中共发生1288例主要终点事件。
  • HRR增高与主要终点发生率降低相关,单变量HR为0.28(95%CI 0.23至0.36),多变量HR为0.60(95%CI 0.48至0.75)。

临床怎么用

  • 在接受瑞加诺生负荷PET心肌灌注显像的患者中,可结合HRR评估死亡和心衰住院风险,尤其在射血分数保留的患者中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether the prognostic value of heart rate responsiveness to pharmacological stress testing as assessed by stress or rest heart-rate ratio (HRR), adds prognostic value to contemporary PET MPI or varies according to ejection fraction (EF) has not been well-studied. METHODS: Consecutive patients undergoing Rb-82 positron emission tomography (PET) between 2019 and 2024 with regadenoson stress testing were included. The Andersen-Gill extension of the Cox model, which incorporates potentially recurrent events, was used to evaluate the association between HRR and the primary outcome, a composite of death or heart failure (HF) hospitalization. Univariable and multivariable models adjusted for clinical and PET-related variables were used. Restricted cubic splines were used to allow for nonlinearity. Interquartile hazard ratios (HRs) comparing the 75th (referent) vs the 25th percentiles of HRR were reported. RESULTS: Over a median follow-up of 553 days (IQR: 232 to 941 days), a total of 1,288 primary outcome events occurred among 7,808 patients. A greater HRR was associated with a lower incidence of the primary outcome in both the univariable (HR: 0.28; 95% CI: 0.23 to 0.36) and multivariable (HR: 0.60; 95% CI: 0.48 to 0.75) models. The association of HRR with the primary outcome was greater at higher EFs (P for interaction: .02), with HRs of 0.69, 0.55, 0.49, and 0.47 at EFs of 40%, 50%, 60%, and 70% respectively. CONCLUSIONS: The prognostic value of HRR after pharmacological stress testing for death and HF hospitalization is most pronounced in patients with a preserved EF and is independent of traditional risk factors and PET parameters, including myocardial flow reserve.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Sayed A, Al Rifai M, El Yaman A, et al. Differential association of heart rate response to regadenoson with death and heart failure hospitalizations according to ejection fraction in patients undergoing positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2025. PMID: 41072605. doi:10.1016/j.nuclcard.2025.102508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。